LUND, Sweden, May 3, 2024 /PRNewswire/ — Hansa Biopharma AB (publ), (“Hansa” or the “Company”) (STO: HNSA) today announced that the company’s registered share capital and number of shares and votes have increased through the issue of 10,474,740 new ordinary shares on 12 April 2024,…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.